Lexpos News

/Lexpos News

PQS declaration questions published

The NHS Business Services Authority (NHSBSA) has published the questions which will be included in the 2025/26 Pharmacy Quality Scheme (PQS) declaration so pharmacy owners can view these ahead of making their declaration when the declaration window opens. The questions are available on the NHSBSA PQS hub page; scroll down to the ‘PQS 2025/26’ section where [...]

The post PQS declaration questions published appeared first on Community Pharmacy England.

By |January 14th, 2026|Lexpos News|Comments Off on PQS declaration questions published

Supporting you in 2026: Our work with Pharmacist Support

Alongside critical work making the financial case for the sector, Community Pharmacy England will be working with Pharmacist Support in 2026 to help support the wellbeing of pharmacists and their teams. The continuing fragility of pharmacy finances, alongside high workloads, stress, ongoing uncertainty and rising reports of patient abuse across England, take a real toll [...]

The post Supporting you in 2026: Our work with Pharmacist Support appeared first on Community Pharmacy England.

By |January 14th, 2026|Lexpos News|Comments Off on Supporting you in 2026: Our work with Pharmacist Support

Discontinuation of Subutex® and Suboxone® tablets

Pharmacy teams should be aware that all strengths of Subutex® and Suboxone® tablets have been discontinued. The manufacturer, Indivior, is no longer supplying these products in the UK therefore, they are no longer available for community pharmacies to order. Please note that if a prescriber has issued a branded prescription for any strength of Subutex®, [...]

The post Discontinuation of Subutex® and Suboxone® tablets appeared first on Community Pharmacy England.

By |January 13th, 2026|Lexpos News|Comments Off on Discontinuation of Subutex® and Suboxone® tablets

Pharmacy First myth busting: To reject or not to reject?

This article tackles some of the misconceptions around rejecting Pharmacy First referrals and aims to bust myths to increase understanding of the service. We have previously published a series of articles on myth busting covering a variety of aspects of Pharmacy First. All of these myths can be viewed on our Pharmacy First service – [...]

The post Pharmacy First myth busting: To reject or not to reject? appeared first on Community Pharmacy England.

By |January 13th, 2026|Lexpos News|Comments Off on Pharmacy First myth busting: To reject or not to reject?

Medicine Supply Notification: Co-codamol 30mg/500mg tablets

Department of Health and Social Care (DHSC) has issued a medicine supply notification for Co-codamol 30mg/500mg tablets. MSN/2026/001 Tier 3 – High impact Date of issue: 12 January 2026 Co-codamol 30mg/500mg tablets will be in limited supply from early February until early June 2026. Paracetamol 500mg tablets remain available and can support a full uplift [...]

The post Medicine Supply Notification: Co-codamol 30mg/500mg tablets appeared first on Community Pharmacy England.

By |January 12th, 2026|Lexpos News|Comments Off on Medicine Supply Notification: Co-codamol 30mg/500mg tablets